Advertisement
SHORT COMMUNICATION
Physiological and pharmacological characterization of a molluscan neuronal efflux transporter; evidence for age-related transporter impairment
Petra M. Hermann, Alexander C. Perry, Izen Hamad, Willem C. Wildering
Journal of Experimental Biology 2020 223: jeb213785 doi: 10.1242/jeb.213785 Published 28 January 2020

ABSTRACT

Plasma membrane efflux transporters play crucial roles in the removal and release of both harmful and beneficial substances from the interior of cells and tissue types in virtually every extant species. They contribute to the clearance of a broad spectrum of exogenous and endogenous toxicants and harmful metabolites, including the reactive lipid aldehyde byproducts of lipid peroxidation that are a hallmark of cellular ageing. Here, we tested whether declining transporter functionality may contribute to functional decline in a snail model of neuronal ageing. Through measuring the removal of 5(6)-carboxyfluorescein, a known substrate for membrane efflux transporters, we provide, for the first time, physiological evidence for the existence of probenecid-, MK571- and glutathione-sensitive efflux transporters in (gastropod) neurons and demonstrate that their functionality declines with age. Our data support the idea that waning cellular detoxification capacity might be a significant factor in the escalation of (lipo-)toxicity observed in neuronal ageing.

INTRODUCTION

Cellular homeostasis, the maintenance of a balanced and stable physico-chemical intracellular environment, is critical to the functional integrity and survival of cells and, ultimately, organisms. Over the course of their lives, cells face many potentially disruptive influences arising either as a side effect of their normal functions, such as chemically reactive byproducts of their own metabolism, or as a consequence of exogenous substances such as drugs, agricultural and industrial chemicals, or other xenobiotics they absorb from their environment. Often, particularly in the case of membrane-impermeant molecules, cells respond to these kinds of challenges with extrusion of the offending substance through specialized plasma membrane transport mechanisms such as members of the highly conserved cation transporters of the solute carrier (SLC) and the ATP-binding cassette (ABC) transporter protein families (Featherstone, 2011; Höglund et al., 2011). SLC transporters function either passively or through secondary active processes and they control transmembrane movement of many types of substrates, including neurotransmitters, metabolites, drugs and toxins (Hediger et al., 2004). ABC transporters constitute one of the largest and evolutionarily oldest families of transmembrane transporters, and representatives of most of the eight (mammalian) subfamilies are found in virtually all extant phyla (Baral, 2017; Dean et al., 2001; Dermauw and van Leeuwen, 2014; Hartz and Bauer, 2011; Jeong et al., 2017). ABC family members are expressed in most animal tissue and cell types, including neurons and glial cells of the nervous system (Abuznait and Kaddoumi, 2012; Brandmann et al., 2014; Dallas et al., 2006; Dean et al., 2001; Falcão et al., 2007; Hartz and Bauer, 2011). The majority of ABC proteins require the binding and hydrolysis of ATP to transport substrates across lipid membranes. Although many ABC transporters may mediate both influx and efflux processes, in eukaryotes they primarily facilitate efflux of unwanted molecules (Dean et al., 2001; Hartz and Bauer, 2011).

Extensive research in the biological correlates of drug resistance or uptake in cells has provided substantial insight into the function of members of the SLC and ABC subfamilies (Briz et al., 2019; DeGorter et al., 2012; Nyquist et al., 2017; Willers et al., 2019). Moreover, their role in the cellular response to environmental toxins and xenobiotics has been well described (Dermauw and van Leeuwen, 2014; Gott et al., 2017; Jeong et al., 2017). Also, although there is a growing awareness of the significance of these transporters in (age-related) neurodegenerative diseases, particularly in their functioning at the blood–brain barrier (Erdő and Krajcsi, 2019; Morris et al., 2017; Sultana and Butterfield, 2004), much less is known of their role in dealing with endogenous chemical perturbations in ageing neurons.

In this study, we investigated this question using the pond snail Lymnaea stagnalis (L.), a gastropod model system of neuronal ageing and age-associated learning and memory impairment (Hermann et al., 2007, 2014). Capitalizing on L. stagnalis’s unique large identifiable neurons, the current study investigated non-pathological, age-associated functional changes of a glutathione-dependent, probenecid- and MK-571-sensitive efflux transporter functionality.

MATERIALS AND METHODS

Animal populations

Snails were bred and raised as described before under constant and strictly controlled conditions in the laboratory (Hermann et al., 2007; Watson et al., 2012a). Briefly, they were raised at a maximal density of 1.5 snails per liter, on a 12 h:12 h light:dark cycle, at an ambient temperature of 19–20°C and fed ad libitum with lettuce and Aquamax-carnivorous Grower 600 trout pellets (Purina Mills LLC, St Louis, MO, USA). The facility uses reverse osmosis water that has been subsequently reconditioned to a conductivity of ∼450 µS cm−1 by adding Instant Ocean salts (Aquarium Systems USA) at 1 g per US gallon (∼3.8l). Calcium carbonate (light powder; EMD Millipore) and sterilized cuttlefish bone were added to the water to maintain a pH of 7.4–7.6 and to keep dissolved calcium concentrations at saturation level (see Johnston et al., 2017, for details of water composition). Survival characteristics of the populations were continuously monitored and evaluated using previously established methods based on the two-parameter Weibull failure model (Janse et al., 1988; Slob and Janse, 1988). Experimental animals were taken at random from differently aged populations meeting Weibull parameters consistent with healthy ageing. For the purpose of this study, old animals (20–24 months of age) are defined as animals sampled from populations with a survival percentage of 20% or less, whereas young sexually mature animals (7–9 months of age) were taken from populations with survival rates of 95% or better.

Neuronal dye labelling

The central nervous system (CNS) was dissected from anaesthetized animals (Watson et al., 2012b) and pinned down in an elastomere-covered dish filled with a Hepes-buffered saline (HBS; for composition, see below). The large identified neuron RPD1 (right parietal dorsal 1; Fig. 1A) was impaled with a microelectrode without the use of proteolytic enzymes (Hermann and Bulloch, 1998; Hermann et al., 1997). Microelectrodes were pulled from borosilicate glass (TW150F, World Precision Instruments, Sarasota, FL, USA) and filled with 5(6)-carboxyfluorescein (CF; 4% w/v) dissolved in 0.5 mol l−1 potassium acetate (CH3COOK)/0.01 mol l−1 KCl. Intra-somatal iontophoretic injection of CF was done through a 30 min pulse protocol of hyperpolarizing square current pulses with duration 500 ms, amplitude 1 nA and repetition rate of 1 Hz generated with a Model 2100 isolated pulse stimulator (A-M Systems, Sequim, WA, USA) and delivered through standard intracellular microelectrode techniques with the aid of an Axoclamp 2A amplifier (Axon Instruments, Burlingame, CA, USA; Fig. 1B).

Fig. 1.
Fig. 1.

Characterization of an efflux transporter in a Lymnaea stagnalis neuron. (A) Photographic example of the location (left) of RPD1 and fluorescence (right) after intra-somatal injection with 5(6)-carboxyfluorescein (CF). (B) Photographic time series of RPD1 CF fluorescence in either saline alone (control) or saline plus the ABC transporter inhibitors probenecid or MK-571. (C) Average change over time in normalized RPD1 CF fluorescence in the absence (saline) or presence of probenecid (10 mmol l−1) or MK-571 (300 µmol l−1). Note the relatively stable fluorescence levels in the presence of the ABC inhibitors. (D) Dose–response curves of the effect of probenecid and MK-571 on CF extrusion rate. IC50 is indicated by the vertical dotted red (MK-571) and green (probenecid) lines. (E) Average single-exponential CF fluorescence decline in RPD1 from young snails under control (saline) conditions or in the presence of the γ-glutamylcysteine synthetase inhibitor BSO. Note the significant slow-down of extrusion in the presence of BSO. (F) Scatter plot of half-life of CF fluorescence in saline or in the presence of BSO (means±s.e.m.). RFU, relative fluorescence units.

Image acquisition and analysis

After injection of CF into the soma of RPD1, dye extrusion was monitored for 3 h (unless indicated otherwise), with sets of five images acquired at a rate of 12 h−1 for the first hour, 4 h−1 during the next hour and 2 h−1 during the third and last hour. Exposure time of individual images was 100 ms. Gain settings were optimized for each experiment. Average fluorescence intensity for each of the sets was calculated as the arithmetic mean of each quintuplet (ImageJ version 1.51j8, NIH, Bethesda, MD, USA). Images were taken with an MVX10 macro zoom fluorescence stereomicroscope (Olympus) with 495 nm excitation/519 nm emission and a Retiga Exi-blue cooled CCD camera (QImaging, Surrey, BC, Canada) controlled through CellSense Dimensions Imaging software (v1.6, Olympus Life Science).

Chemicals and solutions

Unless stated otherwise, chemicals were obtained from Sigma Aldrich (St Louis, MO, USA) and dissolved in HBS. CF (Acros Organics, Branchburg, NJ, USA) was dissolved in microelectrode medium (0.5 mol l−1 potassium acetate/0.01 mol l−1 potassium chloride) to a concentration of 4% with pH set at ∼7.5 with 5 mol l−1 NaOH, and subsequently filtered through a 0.45 µm syringe filter. ABC transporter inhibitors MK-571 and probenecid (water-soluble; Molecular Probes, Eugene, OR, USA), γ-glutamylcysteine synthetase inhibitor buthionine sulphoximine (BSO) and membrane-permeable ethyl ester of reduced glutathione (GSH-EE) were dissolved in HBS at concentrations indicated in the text. Adenosine 5′-triphosphate disodium salt hydrate (ATP) was dissolved in microelectrode medium to a concentration of 10 mmol l−1 and co-injected with CF into the soma of RPD1 as described before (note: to monitor the efficacy of ATP delivery, electrical activity of the injected neurons was monitored for changes indicative of closure of KATP background channels; Fathi-Moghadam and Winlow, 2019). Isolated CNS was placed in saline, BSO, MK-571 or probenecid starting 30 min before impalement; treatment with GSH-EE started 60 min before impalement. All drug applications continued during dye loading and imaging. All experiments were performed in HBS (pH 7.9) with the following composition (in mmol l−1): 51.3 NaCl, 1.7 KCl, 4.1 CaCl2, 1.5 MgCl2 and 10 Hepes.

Data analysis and statistics

Using least-squares non-linear regression techniques, one-phase exponential decay models [Yt=(Y0−Y∞)−kt+Y∞; where Yt is the concentration of dye remaining at time t, Y0 is the value of Y at t=0, k is a rate constant and Y∞ is the asymptotic steady-state value] were fitted to averaged CF fluorescence intensity decay time series. To deal with slight variations in loading efficacy, the models were fitted to data normalized to the mean intensity of the first frame (i.e. Y0=1). Statistical significance was tested using Student's t-test or one-way ANOVA followed by Dunnett's or Šidák's multiple comparisons test where specific hypothesis tests were required. All analyses were performed and all figures made with GraphPad Prism (version 8.0.1, GraphPad Software Inc., La Jolla, CA, USA). All data are represented as arithmetic mean and s.e.m.

RESULTS AND DISCUSSION

Characterization of a neuronal efflux transporter

To monitor the activity of the neuronal efflux transporter(s) in L. stagnalis CNS, we iontophoretically injected the anionic fluorescent dye CF directly into the cytosol of RPD1, thereby circumventing potential (age-associated) variance in probe loading and subcellular compartmentalization commonly associated with esterified-probe loading protocols. Intracellular CF fluorescence intensity in RPD1 from young snails decayed with a single-exponential time course with half-times in the low twenties of minutes (Fig. 1C). In the absence of inhibitors, mean intracellular fluorescence intensity level declined exponentially to 21±1% of its starting value in 60 min (n=6, R2=0.9846; Fig. 1B,C). Treatment with the anion transport inhibitors probenecid or MK-571 slowed CF fluorescence decay in a dose-dependent manner (Fig. 1B–D). Both probenecid and MK-571 displayed steep dose–effect characteristics with an IC50 of 189±51.9 µmol l−1 and 3.3±0.85 µmol l−1, respectively (Fig. 1D), values consistent with or even below previously reported data in mammalian and other invertebrate cells and tissues (Campos et al., 2014; Della Torre et al., 2014; Gekeler et al., 1995; Renes et al., 1999; Salerno and Garnier-Suillerot, 2001). Treatment with maximal doses of probenecid (10 mmol l−1, n=11) or MK-571 (300 µmol l−1, n=6) linearized fluorescence-loss curves and slowed down decay rates to values as low as −1.3(±0.021)×10−3 min−1 and −1.6(±0.014)×10−3 min−1, respectively. Importantly, in both instances, residual fluorescence intensity levels declined to only 91±2% and 90±6% of their initial values after undergoing 60 min of exactly the same sampling protocol and exposure conditions to the untreated preparations (Fig. 1C), indicating that photobleaching had little or no effect on the disappearance of CF fluorescence in the latter preparations.

Together, the above results show that RPD1 express an efflux transporter with a pharmacological profile characteristic of ABCC transporters (Hagos et al., 2017; Yamazaki et al., 2005). Parenthetically, it is important to note that CF is a known substrate for members of the ABCC subfamily (Da Costa et al., 2018; Valdez et al., 2017; Van der Kolk et al., 1998).

Postulating involvement of an ABC transporter sharing characteristics with the ABCC subfamily, we tested GSH dependency of CF extrusion (Bachhawat et al., 2013; Ballatori et al., 2009; Cole and Deeley, 2006). To this end, CNS isolated from young animals was preincubated with the γ-glutamylcysteine synthetase inhibitor BSO (10 mmol l−1; n=6). As shown in Fig. 1E, pretreatment with BSO significantly slowed down CF extrusion, yielding a (mean±s.e.m.) first-order decay rate constant of 0.019±0.001 RFU min−1 compared with 0.031±0.001 RFU min−1 under control conditions (Student’s t=5.72, P<0.001, d.f.=10; R2saline=0.9860; R2BSO=0.9625), corresponding to an ,increase in average fluorescence intensity half-life from 22.8±0.95 min to 36.7±2.76 min (Fig. 1F; Student’s t=4.79, P<0.001, d.f.=10), thus corroborating the hypothesis that CF extrusion in RPD1 is mediated by a transporter sharing defining pharmacological and physiological traits with the ABCC subfamily. A L. stagnalis transcriptome data search indicated that L. stagnalis expresses a large variety of ABC transporter homologues, including six members of the ABCC subfamily (ABCC1–5 and ABCC12; Bouétard et al., 2012; Rosenegger et al., 2010). At least two MK571 and probenecid-sensitive ABCC member homologues (ABCC1 and ABCC4) seem to be expressed in L. stagnalis CNS (Feng et al., 2009). Although the existence of mammalian neuronal ABCC efflux transporters has been reported before (Brandmann et al., 2014; Falcão et al., 2007; Grube et al., 2018), the data presented here provide the first physiological and functional evidence for the existence of such an efflux transporter in non-mammalian neurons.

Dye-extrusion rate declines with age

In the light of our earlier work on functional and metabolic decline of the ageing L. stagnalis CNS (Lee, 2019; Hermann et al., 2014; Watson et al., 2012a, 2013), we examined whether neuronal CF extrusion capacity declines with age. To this end, the disappearance of CF fluorescence from RPD1 in the CNS of six young and eight old snails was measured and analysed as above (Fig. 2A). Again, the time course of CF fluorescence decline followed single-exponential kinetics (Fig. 2B; R2young=0.9860; R2old=0.9701). However, fluorescence intensity levels declined significantly faster in young neurons than in old neurons, with average decay rate constants of 0.031±0.001 RFU min−1 and 0.022±0.001 RFU min−1 in young and old preparations, respectively (Fig. 2A,B; Student’s t=4.044, P=0.016, d.f.=12), corresponding to an increase in fluorescence half-life from 22.8±0.95 min to 32.4±1.81 min, respectively (Fig. 2C; Student’s t=4.29, P=0.001, d.f.=12). Intriguingly, both decay rate constants and half-life of old RPD1 are similar to those reported above for the BSO-treated young RPD1 (cf. Figs 1F and 2C). Importantly, treatment with 10 mmol l−1 probenecid reduced fluorescence decay in both young and old preparations to the same minimal rate (Fig. 2D; ANOVA F3,29=217.8, P<0.0001; Šidák's multiple comparisons tests: young versus old, t4=2.71, P<0.04; young versus young+probenecid t4=19.68, P<0.001; old versus old+probenecid t4=16.07, P<0.001; young+probenecid versus old+probenecid t4=1.05, P=0.76). Thus, after 60 min, fluorescence levels were similar in young and old preparations, and still at 91±2% and 88±3%, respectively, of their initial values (Fig. 2D). Again, this indicates that photobleaching or other processes potentially quenching CF fluorescence (Elliott and Kleindienst, 1990; Song et al., 1995) had little or no effect on the current results. Consequentially, the marked slow-down in CF fluorescence decay of older neurons presumably involves an age-associated decline in the extrusion capacity of the probenecid/MK-571-sensitive plasma membrane efflux transporter(s).

Fig. 2.
Fig. 2.

Age-associated reduction in efflux transporter functioning. (A) Time series of CF fluorescence decay in RPD1 from young and old snails. (B) Average single-exponential CF fluorescence decline in RPD1 of young and old animals. Note the significant slow-down of dye extrusion in old RPD1. (C) Scatter plot of half-life of CF fluorescence in young and old RPD1 (means±s.e.m.). (D) Average CF fluorescence after 60 min of saline or probenecid treatment in young and old RPD1. Note that probenecid treatment prevents dye extrusion in both young and old preparations to the same extent. *P<0.05, ***P<0.001; n.s., not significant; RFU, relative fluorescence units.

GSH and/or ATP supplementation do not affect transporters in aged neurons

All classes of ABC transporters operate at the expense of ATP and some also require GSH (Cole and Deeley, 2006). As we demonstrated above, RPD1's CF transporter belongs to the latter group. As reported previously, GSH and ATP supplies are diminishing in ageing L. stagnalis neurons (Lee, 2019; Watson et al., 2014), prompting us to test the effect of ATP, GSH or ATP plus GSH supplementation on CF extrusion rates in old RPD1. Fig. 3A,C illustrates that compared with saline-only controls, neither supplementation of intracellular GSH by means of GSH-EE (10 mmol l−1, n=6) or injection of ATP (10 mmol l−1, n=7) effected significant changes in CF fluorescence decay kinetics (Fig. 3A–D). As before, the fluorescence decay curves were fitted very well by single-exponential decay models (R2saline=0.9701; R2GSH-EE=0.9651; R2ATP=0.9742) with mean decay rates of 0.022±0.001 RFU min−1, 0.019±0.002 RFU min−1 and 0.025±0.002 RFU min−1 for saline-only, GSH-EE-treated or ATP-injected preparations, respectively. These decay rates did not differ significantly from each other (ANOVA F3,23=3.694, P=0.026; Dunnett's test: saline-only versus GSH-EE, Q=1.245, P=0.481, d.f.=23; saline-only versus ATP, Q=1.044 P=0.615, d.f.=23). Likewise, CF fluorescence decay in cells that received the GSH/ATP combination treatment (Fig. 3E) could be fitted very well with a single-exponential decay model (R2GSH+ATP=0.9856) with a mean decay rate of 0.017±0.001 RFU min−1. Notably, the combined treatment also failed to reverse the slow-down of CF extrusion in older RPD1 (Fig. 3F). In fact, the data suggest that even though this effect was not statistically significant, the combined treatment may cause CF extrusion to decelerate even further (ANOVA F3,23=3.694, P=0.026; Dunnett’s test: saline-only versus GSH/ATP, Q=2.177, P=0.1023, d.f.=23).

Fig. 3.
Fig. 3.

GSH and/or ATP supplementation does not accelerate extrusion rate in old neurons. (A) Average CF fluorescence decay time series in old RPD1 with and without treatment with ATP. (B) Scatter plot of CF fluorescence half-life in old RPD1 with or without ATP injection (means±s.e.m.). (C) Average CF fluorescence decay time series in old RPD1 in saline or with membrane-permeable ethyl ester of reduced glutathione (GSH-EE). (D) Scatter plot of CF fluorescence half-life in old RPD1 in saline or with GSH-EE (means±s.e.m.). (E) Average single-exponential CF fluorescence decline in old RPD1 in saline or with a combination of ATP and GSH-EE. (F) Scatter plot of CF fluorescence half-life in old RPD1 in saline or a combination of ATP and GSH-EE (means±s.e.m.). RFU, relative fluorescence units.

Together, these results show that enhancing intracellular GSH and/or ATP levels does not return old neurons to the higher CF extrusion rates characteristic of young neurons. Importantly, indicative of successful delivery of both compounds, we noticed resting membrane potential depolarization and/or increased electrical activity of injected RPD1 in all cases (data not shown). Previous studies have shown that intracellular ATP concentrations ([ATP]i) >2 mmol l−1 are required to inhibit ATP-sensitive background potassium channels in L. stagnalis neurons underlying this ATP response (Fathi-Moghadam and Winlow, 2019; Lozovaya et al., 1993). Moreover, normal cytosolic ATP concentration in (mammalian) neurons is estimated to be between 1 and 3 mmol l−1 (Ainscow et al., 2002; Chinopoulos et al., 2000; Pathak et al., 2015; Rangaraju et al., 2014). Thus, even though we could not measure final [ATP]i in our experiments, ATP injections probably increased [ATP]i in excess of 1–2 mmol l−1.

Our results raise the question why probenecid/MK-571-sensitive efflux transporter capacity of L. stagnalis neurons declines with age. We can as yet not answer this question with certainty. However, several studies have shown an age-related attenuation of expression levels of efflux transporters (including ABC transporters) located at the blood–brain barrier (Erdő and Krajcsi, 2019; Erickson and Banks, 2019). Hence, it is conceivable that the CF efflux transporter capacity of RPD1 is affected by an age-associated decline in transporter protein expression. Alternatively, many ABC transporter proteins, including members of the ABCC subfamily, possess redox-sensitive cysteine residues, the oxidation of which under oxidative stress conditions disrupts their transporter activity (Kuo, 2009). Hence, age-associated escalation of oxidative stress, one of the hallmarks of ageing in the vast majority of model systems including the L. stagnalis nervous system, may contribute to the phenomena reported here (Hermann et al., 2014; Watson et al., 2012a). Last but not least, considering the important role ABC(C) transporters play in the removal of toxic endogenous compounds including reactive lipid aldehydes, reduced efflux capacity might lead to an accumulation of these compounds and as a result further negatively affect the functioning of these transporters (Ji et al., 2002; Jungsuwadee et al., 2006; Renes et al., 2000; Sultana and Butterfield, 2004; Zhang and Forman, 2017).

In conclusion, the results presented here provide evidence that functioning of an efflux transporter, with the pharmacological characteristics of an ABCC-like transporter, attenuates with age in L. stagnalis neurons and furthers our theory that declining cellular detoxification capacity is a factor in the functional decline of normal ageing neurons.

FOOTNOTES

  • Competing interests

    The authors declare no competing or financial interests.

  • Author contributions

    Conceptualization: P.M.H., W.C.W.; Methodology: P.M.H., A.C.P.; Validation: P.M.H., W.C.W.; Formal analysis: P.M.H., W.C.W.; Data curation: P.M.H., A.C.P., I.H.; Writing - original draft: P.M.H., W.C.W.; Writing - review & editing: P.M.H., W.C.W.; Supervision: W.C.W.; Funding acquisition: W.C.W.

  • Funding

    The work was supported by a National Science and Engineering Research Council of Canada (NSERC) operating grant to W.C.W.

  • Received September 3, 2019.
  • Accepted January 6, 2020.

References

  1. ↵
    1. Abuznait, A. H. and
    2. Kaddoumi, A.
    (2012). Role of ABC transporters in the pathogenesis of Alzheimer's disease. ACS Chem. Neurosci. 3, 820-831. doi:10.1021/cn300077c
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ainscow, E. K.,
    2. Mirshamsi, S.,
    3. Tang, T.,
    4. Ashford, M. L. J. and
    5. Rutter, G. A.
    (2002). Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat hypothalamic neurones: evidence for ATP-independent control of ATP-sensitive K+ channels. J. Physiol. 544, 429-445. doi:10.1113/jphysiol.2002.022434
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Bachhawat, A. K.,
    2. Thakur, A.,
    3. Kaur, J. and
    4. Zulkifli, M.
    (2013). Glutathione transporters. Biochim. Biophys. Acta. 1830, 3154-3164. doi:10.1016/j.bbagen.2012.11.018
    OpenUrlCrossRefPubMed
  4. ↵
    1. Ballatori, N.,
    2. Krance, S. M.,
    3. Marchan, R. and
    4. Hammond, C. L.
    (2009). Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol. Aspects Med. 30, 13-28. doi:10.1016/j.mam.2008.08.004
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Baral, B.
    (2017). Evolutionary trajectories of entomopathogenic fungi ABC transporters. Adv. Genet. 98, 117-154. doi:10.1016/bs.adgen.2017.07.002
    OpenUrlCrossRef
  6. ↵
    1. Bouétard, A.,
    2. Noirot, C.,
    3. Besnard, A. L.,
    4. Bouchez, O.,
    5. Choisne, D.,
    6. Robe, E.,
    7. Klopp, C.,
    8. Lagadic, L. and
    9. Coutellec, M. A.
    (2012). Pyrosequencing-based transcriptomic resources in the pond snail Lymnaea stagnalis, with a focus on genes involved in molecular responses to diquat-induced stress. Ecotoxicol. 21, 2222-2234. doi:10.1007/s10646-012-0977-1
    OpenUrlCrossRefPubMed
  7. ↵
    1. Brandmann, M.,
    2. Hohnholt, M. C.,
    3. Petters, C. and
    4. Dringen, R.
    (2014). Antiretroviral protease inhibitors accelerate glutathione export from viable cultured rat neurons. Neurochem. Res. 39, 883-892. doi:10.1007/s11064-014-1284-4
    OpenUrlCrossRef
  8. ↵
    1. Briz, O.,
    2. Perez-Silva, L.,
    3. Al-Abdulla, R.,
    4. Abete, L.,
    5. Reviejo, M.,
    6. Romero, M. R. and
    7. Marin, J. J. G.
    (2019). What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs. Expert Opin. Drug Metab. Toxicol. 15, 577-593. doi:10.1080/17425255.2019.1631285
    OpenUrlCrossRef
  9. ↵
    1. Campos, B.,
    2. Altenburger, R.,
    3. Gómez, C.,
    4. Lacorte, S.,
    5. Piña, B.,
    6. Barata, C. and
    7. Luckenbach, T.
    (2014). First evidence for toxic defense based on the multixenobiotic resistance (MXR) mechanism in Daphnia magna. Aquat. Toxicol. 148, 139-151. doi:10.1016/j.aquatox.2014.01.001
    OpenUrlCrossRef
  10. ↵
    1. Chinopoulos, C.,
    2. Tretter, L.,
    3. Rozsa, A. and
    4. Adam-Vizi, V.
    (2000). Exacerbated responses to oxidative stress by an Na(+) load in isolated nerve terminals: the role of ATP depletion and rise of [Ca(2+)]i. J. Neurosci. 20, 2094-2103. doi:10.1523/JNEUROSCI.20-06-02094.2000
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Cole, S. P. C. and
    2. Deeley, R. G.
    (2006). Transport of glutathione and glutathione conjugates by MRP1. TRENDS in Pharm. Sci. 27, 438-446. doi:10.1016/j.tips.2006.06.008
    OpenUrlCrossRef
  12. ↵
    1. da Costa, K. M.,
    2. Valente, R. C.,
    3. Salustiano, E. J.,
    4. Gentile, L. B.,
    5. Freire-de-Lima, L.,
    6. Mendonça-Previato, L. and
    7. Previato, J. O.
    (2018). Functional characterization of ABCC proteins from Trypanosoma cruzi and their involvement with thiol transport. Front. Microbiol. 9, 205. doi:10.3389/fmicb.2018.00205
    OpenUrlCrossRef
  13. ↵
    1. Dallas, S.,
    2. Miller, D. S. and
    3. Bendayan, R.
    (2006). Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev. 58, 140-161. doi:10.1124/pr.58.2.3
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Dean, M.,
    2. Rzhetsky, A. and
    3. Allikmets, R.
    (2001). The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156-1166. doi:10.1101/gr.GR-1649R
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. DeGorter, M. K.,
    2. Xia, C. Q.,
    3. Yang, J. J. and
    4. Kim, R. B.
    (2012). Drug transporters in drug efficacy and toxicity. Ann. Rev. Pharmacol. Toxicol. 52, 249-273. doi:10.1146/annurev-pharmtox-010611-134529
    OpenUrlCrossRefPubMed
  16. ↵
    1. Della Torre, C.,
    2. Bocci, E.,
    3. Focardi, S. E. and
    4. Corsi, I.
    (2014). Differential ABCB and ABCC gene expression and efflux activities in gills and hemocytes of Mytilus galloprovincialis and their involvement in cadmium response. Mar. Environ. Res. 93, 56-63. doi:10.1016/j.marenvres.2013.06.005
    OpenUrlCrossRef
  17. ↵
    1. Dermauw, W. and
    2. Van Leeuwen, T.
    (2014). The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance. Insect Biochem. Mol. Biol. 45, 89-110. doi:10.1016/j.ibmb.2013.11.001
    OpenUrlCrossRefPubMed
  18. ↵
    1. Elliott, C. J. H. and
    2. Kleindienst, H.-U.
    (1990). Photoinactivation of neurones in the pond snail, Lymnaea stagnalis: estimation of a safety factor. Brain Res. 524, 149-152. doi:10.1016/0006-8993(90)90504-5
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Erdő, F. and
    2. Krajcsi, P.
    (2019). Age-Related functional and expressional changes in efflux pathways at the blood-brain barrier. Front. Aging Neurosci. 11, 196. doi:10.3389/fnagi.2019.00196
    OpenUrlCrossRef
  20. ↵
    1. Erickson, M. A. and
    2. Banks, W. A.
    (2019). Age-associated changes in the immune system and blood-brain barrier functions. Int. J. Mol. Sci. 20, E1632. doi:10.3390/ijms20071632
    OpenUrlCrossRef
  21. ↵
    1. Falcão, A. S.,
    2. Bellarosa, C.,
    3. Fernandes, A.,
    4. Brito, M. A.,
    5. Silva, R. FM.,
    6. Tiribelli, C. and
    7. Brites, D.
    (2007). Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neurosci. 144, 878-888. doi:10.1016/j.neuroscience.2006.10.026
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Fathi-Moghadam, H. and
    2. Winlow, W.
    (2019). Pharmacological dissection of potassium currents in cultured, identified, molluscan neurons. EC Neurol. 11.5, 346-356.
    OpenUrl
  23. ↵
    1. Featherstone, D. E.
    (2011). Glial solute carrier transporters in drosophila and mice. Glia 59, 1351-1363. doi:10.1002/glia.21085
    OpenUrlCrossRefPubMed
  24. ↵
    1. Feng, Z.-P.,
    2. Zhang, Z.,
    3. van Kesteren, R. E.,
    4. Straub, V. A.,
    5. van Nierop, P.,
    6. Jin, K.,
    7. Nejatbakhsh, N.,
    8. Goldberg, J. I.,
    9. Spencer, G. E.,
    10. Yeoman, M. S. et al.
    (2009). Transcriptome analysis of the central nervous system of the mollusc Lymnaea stagnalis. BMC Genomics. 10, 451. doi:10.1186/1471-2164-10-451
    OpenUrlCrossRefPubMed
  25. ↵
    1. Gekeler, V.,
    2. Ise, W.,
    3. Sanders, K. H.,
    4. Ulrich, W.-R.
    5. Beck, J.
    (1995). The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208, 3453-3452. doi:10.1006/bbrc.1995.1344
    OpenUrlCrossRef
  26. ↵
    1. Gott, R. C.,
    2. Kunkel, G. R.,
    3. Zobel, E. S.,
    4. Lovett, B. R. and
    5. Hawthorne, D. J.
    (2017). Implicating ABC transporters in insecticide resistance: research strategies and a decision framework. J. Econ. Entomol. 110, 667-677. doi:10.1093/jee/tox041
    OpenUrlCrossRef
  27. ↵
    1. Grube, M.,
    2. Hagen, P. and
    3. Jedlitschky, G.
    (2018). Neurosteroid transport in the brain: role of ABC and SLC transporters. Front. Pharmacol. 9, 354. doi:10.3389/fphar.2018.00354
    OpenUrlCrossRef
  28. ↵
    1. Hagos, F. T.,
    2. Daood, M. J.,
    3. Ocque, J. A.,
    4. Nolin, T. D.,
    5. Bayir, H.,
    6. Poloyac, S. M.,
    7. Kochanek, P. M.,
    8. Clark, R. S. and
    9. Empey, P. E.
    (2017). Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine. Xenobiotica 47, 346-353. doi:10.1080/00498254.2016.1187777
    OpenUrlCrossRefPubMed
  29. ↵
    1. Hartz, A. M. and
    2. Bauer, B.
    (2011). ABC transporters in the CNS–an inventory. Curr. Pharm. Biotechnol. 12, 656-673. doi:10.2174/138920111795164020
    OpenUrlCrossRefPubMed
  30. ↵
    1. Hediger, M. A.,
    2. Romero, M. F.,
    3. Peng, J.-B.,
    4. Rolfs, A.,
    5. Takanaga, H. and
    6. Bruford, E. A.
    (2004). The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins Introduction. Pflügers Arch. 447, 465-468. doi:10.1007/s00424-003-1192-y
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Hermann, P. M. and
    2. Bulloch, A. G. M.
    (1998). Pronase modifies synaptic transmission and activity of identified Lymnaea neurons. Inv. Neurosci. 3, 295-304. doi:10.1007/BF02577689
    OpenUrlCrossRef
  32. ↵
    1. Hermann, P. M.,
    2. Lukowiak, K.,
    3. Wildering, W. C. and
    4. Bulloch, A. G. M.
    (1997). Pronase acutely modifies high voltage-activated calcium currents and cell properties of Lymnaea neurons. Eur. J. Neurosci. 9, 2624-2633. doi:10.1111/j.1460-9568.1997.tb01692.x
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Hermann, P. M.,
    2. Lee, A.,
    3. Hulliger, S.,
    4. Minvielle, M.,
    5. Ma, B. and
    6. Wildering, W. C.
    (2007). Impairment of long-term associative memory in aging snails (Lymnaea stagnalis). Behav. Neurosci. 121, 1400-1414. doi:10.1037/0735-7044.121.6.1400
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Hermann, P. M.,
    2. Watson, S. N. and
    3. Wildering, W. C.
    (2014). Phospholipase A2 – nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment. Front. Genet. 5, 419. doi:10.3389/fgene.2014.00419
    OpenUrlCrossRefPubMed
  35. ↵
    1. Höglund, P. J.,
    2. Nordström, K. J. V.,
    3. Schiöth, H. B. and
    4. Fredriksson, R.
    (2011). The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species. Mol. Biol. Evol. 28, 1531-1541. doi:10.1093/molbev/msq350
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Janse, C.,
    2. Slob, W.,
    3. Popelier, C. M. and
    4. Vogelaar, J. W.
    (1988). Survival characteristics of the mollusc Lymnaea stagnalis under constant culture conditions: effects of aging and disease. Mech. Ageing Dev. 42, 263-274. doi:10.1016/0047-6374(88)90052-8
    OpenUrlCrossRefPubMed
  37. ↵
    1. Jeong, C.-B.,
    2. Kim, H.-S.,
    3. Kang, H.-M. and
    4. Lee, J.-S.
    (2017). ATP-binding cassette (ABC) proteins in aquatic invertebrates: Evolutionary significance and application in marine ecotoxicology. Aquatic Toxicol. 185, 29-39. doi:10.1016/j.aquatox.2017.01.013
    OpenUrlCrossRef
  38. ↵
    1. Ji, B.,
    2. Ito, K.,
    3. Suzuki, H.,
    4. Sugiyama, Y. and
    5. Horie, T.
    (2002). Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal. Free Radic. Biol. Med. 33, 370-378. doi:10.1016/S0891-5849(02)00906-1
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Johnston, C. U.,
    2. Clothier, L. N.,
    3. Quesnel, D. M.,
    4. Gieg, L. M.,
    5. Chua, G.,
    6. Hermann, P. M. and
    7. Wildering, W. C.
    (2017). Embryonic exposure to model naphthenic acids delays growth and hatching in the pond snail Lymnaea stagnalis. Chemosphere 168, 1578-1588. doi:10.1016/j.chemosphere.2016.11.156
    OpenUrlCrossRef
  40. ↵
    1. Jungsuwadee, P.,
    2. Cole, M. P.,
    3. Sultana, R.,
    4. Joshi, G.,
    5. Tangpong, J.,
    6. Butterfield, D. A.,
    7. St.
    8. Clair, D. K. and
    9. Vore, M.
    (2006). Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6mice. Mol. Cancer Ther. 5, 2851-2860. doi:10.1158/1535-7163.MCT-06-0297
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Kuo, M. T.
    (2009). Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid. Redox. Signal. 11, 99-133. doi:10.1089/ars.2008.2095
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Lee, J. R.
    (2019). Mitochondria and fatty acid homeostasis in the aging nervous system. Ph.D. Thesis, University of Calgary, Calgary, AB, Canada.
  43. ↵
    1. Lozovaya, N. A.,
    2. Vulfius, C. A.,
    3. Ilyin, V. I. and
    4. Krasts, I. V.
    (1993). Intracellular ATP modifies the voltage dependence of the fast transient outward K+ current in Lymnaea stagnalis neurones. J. Physiol. 464, 441-455. doi:10.1113/jphysiol.1993.sp019644
    OpenUrlCrossRef
  44. ↵
    1. Morris, M. E.,
    2. Rodriguez-Cruz, V. and
    3. Felmlee, M. A.
    (2017). SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal Fluid barriers. AAPS J. 19, 1317-1331. doi:10.1208/s12248-017-0110-8
    OpenUrlCrossRef
  45. ↵
    1. Nyquist, M. D.,
    2. Prasad, B. and
    3. Mostaghel, E. A.
    (2017). Harnessing solute carrier transporters for precision oncology. Molecules 22, 539. doi:10.3390/molecules22040539
    OpenUrlCrossRef
  46. ↵
    1. Pathak, D.,
    2. Shields, L. Y.,
    3. Mendelsohn, B. A.,
    4. Haddad, D.,
    5. Lin, W.,
    6. Gerencser, A. A.,
    7. Kim, H.,
    8. Brand, M. D.,
    9. Edwards, R. H. and
    10. Nakamura, K.
    (2015). The role of mitochondrially derived ATP in synaptic vesicle recycling. J. Biol. Chem. 290, 22325-22336. doi:10.1074/jbc.M115.656405
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Rangaraju, V.,
    2. Calloway, N. and
    3. Ryan, T. A.
    (2014). Activity-driven local ATP synthesis is required for synaptic function. Cell 156, 825-835. doi:10.1016/j.cell.2013.12.042
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Renes, J.,
    2. de Vries, E. G.,
    3. Nienhuis, E. F.,
    4. Jansen, P. L. M. and
    5. Müller, M.
    (1999). ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br. J. Pharmacol. 126, 681-688. doi:10.1038/sj.bjp.0702360
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Renes, J.,
    2. de Vries, E. E.,
    3. Hooiveld, G. J.,
    4. Krikken, I.,
    5. Jansen, P. L. and
    6. Müller, M.
    (2000). Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350, 555-561. doi:10.1042/bj3500555
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Rosenegger, D.,
    2. Wright, C. and
    3. Lukowiak, K.
    (2010). A quantitative proteomic analysis of long-term memory. Mol. Brain 3, 9. doi:10.1186/1756-6606-3-9
    OpenUrlCrossRefPubMed
  51. ↵
    1. Salerno, M. and
    2. Garnier-Suillerot, A.
    (2001). Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells. Eur. J. Pharmacol. 421, 1-9. doi:10.1016/S0014-2999(01)00992-X
    OpenUrlCrossRefPubMed
  52. ↵
    1. Slob, W. and
    2. Janse, C.
    (1988). A quantitative method to evaluate the quality of interrupted animal cultures in aging studies. Mech. Ageing Dev. 42, 275-290. doi:10.1016/0047-6374(88)90053-X
    OpenUrlCrossRefPubMedWeb of Science
  53. ↵
    1. Song, L.,
    2. Hennink, E. J.,
    3. Young, T. and
    4. Tanke, H. J.
    (1995). Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy. Biophys. J. 68, 2588-2600. doi:10.1016/S0006-3495(95)80442-X
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Sultana, R. and
    2. Butterfield, D. A.
    (2004). Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 29, 2215-2220. doi:10.1007/s11064-004-7028-0
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Valdez, B. C.,
    2. Hassan, M. and
    3. Andersson, B. S.
    (2017). Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions. Exp. Hematol. 52, 65-71. doi:10.1016/j.exphem.2017.04.011
    OpenUrlCrossRef
  56. ↵
    1. Van der Kolk, D. M.,
    2. de Vries, E. G.,
    3. Koning, J. A.,
    4. van den Berg, E.,
    5. Muller, M. and
    6. Vellenga, E.
    (1998). Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clin. Cancer Res. 4, 1727-1736. doi:10.1038/sj.leu.2402236
    OpenUrlAbstract
  57. ↵
    1. Watson, S. N.,
    2. Nelson, M. A. and
    3. Wildering, W. C.
    (2012a). Redox agents modulate neuronal activity and reproduce physiological aspects of neuronal aging. Neurobiol. Aging. 33, 149-161. doi:10.1016/j.neurobiolaging.2010.01.017
    OpenUrlCrossRefPubMed
  58. ↵
    1. Watson, S. N.,
    2. Risling, T. E.,
    3. Hermann, P. M. and
    4. Wildering, W. C.
    (2012b). Failure of delayed nonsynaptic neuronal plasticity underlies age-associated long-term associative memory impairment. BMC Neurosci. 13, 103. doi:10.1186/1471-2202-13-103
    OpenUrlCrossRefPubMed
  59. ↵
    1. Watson, S. N.,
    2. Wright, N.,
    3. Hermann, P. M. and
    4. Wildering, W. C.
    (2013). Phospholipase A2: the key to reversing long-term memory impairment in a gastropod model of aging. Neurobiol. Aging. 34, 610-620. doi:10.1016/j.neurobiolaging.2012.02.028
    OpenUrlCrossRefPubMedWeb of Science
  60. ↵
    1. Watson, S. N.,
    2. Lee, J. R.,
    3. Risling, T. E.,
    4. Hermann, P. M. and
    5. Wildering, W. C.
    (2014). Diminishing glutathione availability and age-associated decline in neuronal excitability. Neurobiol. Aging. 35, 1074-1085. doi:10.1016/j.neurobiolaging.2013.11.007
    OpenUrlCrossRef
  61. ↵
    1. Willers, C.,
    2. Svitina, H.,
    3. Rossouw, M. J.,
    4. Swanepoel, R. A.,
    5. Hamman, J. H. and
    6. Gouws, C.
    (2019). Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux. J. Cancer Res. Clin. Oncol. 145, 1949-1976. doi:10.1007/s00432-019-02973-5
    OpenUrlCrossRef
  62. ↵
    1. Yamazaki, M.,
    2. Li, B.,
    3. Louie, S. W.,
    4. Pudvah, N. T.,
    5. Stocco, R.,
    6. Wong, W.,
    7. Abramovitz, M.,
    8. Demartis, A.,
    9. Laufer, R.,
    10. Hochman, J. H. et al.
    (2005). Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica 35, 737-753. doi:10.1080/00498250500136676
    OpenUrlCrossRefPubMedWeb of Science
  63. ↵
    1. Zhang, H. and
    2. Forman, H. J.
    (2017). 4-hydroxynonenal-mediated signaling and aging. Free Radic. Biol. Med. 111, 219-225. doi:10.1016/j.freeradbiomed.2016.11.032
    OpenUrlCrossRef
View Abstract
Back to top

Keywords

 Download PDF

Email
SHORT COMMUNICATION
Physiological and pharmacological characterization of a molluscan neuronal efflux transporter; evidence for age-related transporter impairment
Petra M. Hermann, Alexander C. Perry, Izen Hamad, Willem C. Wildering
Journal of Experimental Biology 2020 223: jeb213785 doi: 10.1242/jeb.213785 Published 28 January 2020
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article navigation

Other journals from The Company of Biologists

Advertisement

The Company of Biologists commits to the Transformative Journal approach

The Company of Biologists is the first not-for-profit publisher to commit to this approach. The Company's three hybrid journals - Development, Journal of Cell Science and Journal of Experimental Biology - have chosen the 'transformative' route towards Open Access. Find out more in this interview with Claire Moulton, Publisher at The Company of Biologists and on our dedicated Transformative Journals page.

Handing over the reins

Photo of Hans Hoppeler and Craig Franklin

The start of August signals a change for Journal of Experimental Biology as we say a fond farewell to Editor-in-Chief of 25 years Hans Hoppeler and extend a warm welcome to his successor, Craig Franklin.

Minute mecysmaucheniid spider triggers fastest trap-jaws

Research by Hannah Wood shows that Zearchaea spiders use a spring loaded catapult mechanism to slam closed the fastest spider jaws on the planet, at an astonishing speed of 18.2 m s−1.

In the field: an interview with Sandra Binning and Dominique Roche

Photo of Sarah Binning and Dominique Roche

Together, Sandra Binning and Dominique Roche investigate how animals respond to environmental stress. In an interview, they talk about taking their children into the field and keeping safe while working in marine locations.

Surviving anoxia: the maintenance of energy production and tissue integrity during anoxia and reoxygenation

In their Review, Georgina Cox and Todd Gillis use knowledge gained from studies of anoxia-tolerant species to identify common strategies and novel solutions for the challenges of anoxia exposure.